Benjamin Linas | Profiles RNS

Benjamin Linas, MD

Associate Professor

Boston University School of Medicine

Dept of Medicine

Infectious Diseases

MD, New York University School of Medicine
MPH, Harvard School of Public Health

Websites

	Boston Medical Center Physician Provider Profile
	Boston-Providence Center for AIDS Research
	NIDA Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV, and HIV
	Harvard Prevention Policy Modeling Lab

ORCID : 0000-0001-9574-7075

Dr. Linas is a national leader in hepatitis-C virus (HCV) infection and HCV/HIV co-infection comparative- and cost-effectiveness research using computational biology, clinical epidemiology and clinical economics methods. Dr. Linas has an excellent track record of productivity, ample funding from the NIH and CDC, and a growing core of successful trainees. Dr. Linas directs the HIV/HCV core of the Center for Health Economics of Treatment Interventions for Substance Use Disorders, HCV, and HIV, funded by the National Institute on Drug Abuse (NIDA) in collaboration with Cornell, U Penn and Miami.

Associate Professor
Boston University School of Public Health
Epidemiology

BMC Sponsored Research
NIH RePORTER Sponsored Research

A Cluster RCT to Increase HIV Testing in Substance Use Treatment Programs
09/01/2016 - 07/31/2021 (PI)
Trustees of Columbia University NIH-NIDA

Economic Modeling for HIV, Viral Hepatitis, STD, TB and School Health
09/30/2014 - 09/29/2018 (PI)
Harvard School of Public Health CDC

Lifespan/Tufts/brown Center for AIDS Research (CFAR): Core B Developmental (Pilot Projects)
07/01/2016 - 06/30/2018 (PI)
Miriam Hospital NIH-NIAID

Health Economics of Substance Abuse and HCV/HIV Treatment in the Era of Integrated Health Care - …
09/01/2017 - 04/30/2018 (PI)
Weill Cornell Medical College NIH-NIDA

Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health..
07/01/2015 - 04/30/2018 (PI)
Cornell University NIH-NIDA

Economic Analysis of Rapid HIV and HCV Testing in Drug Abuse Treatment Programs
02/15/2015 - 01/31/2018 (PI)
Cornell University NIH-NIDA

Intensive Models of HCV Care for Injection Drug Users
07/15/2012 - 06/30/2017 (PI)
AlbertEinsteinCllgeOfMed of Yeshiva U. NIH-NIDA

Simulation Modeling to Improve HIV/HCV Screening, Treatment & Care - Supplement
06/01/2014 - 05/31/2017 (PI)
NIH-NIDA
5R01DA031059-04

Simulation Modeling to Improve HIV/HCV Screening, Treatment & Care
06/15/2012 - 05/31/2017 (PI)
NIH-NIDA
5R01 DA031059-04

TO#3 Strategic Timing of Antiretroviral Treatment (START) - INSIGHT
12/01/2010 - 05/31/2017 (PI)
Institute for Clinical Research, Inc. NIH-NIAID

Showing 10 of 14 results. Show All Results

Yr	Title	Project-Sub Proj	Pubs
2017	Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care (HCV + HIV Core)	5P30DA040500-03-6229	1
2016	Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care (HCV + HIV Core)	5P30DA040500-02-6229	1
2015	Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care (HCV + HIV Core)	1P30DA040500-01-6229	1
2014	Simulation Modeling to Improve HIV/HCV Screening, Treatment and Care	3R01DA031059-03S1	13
2014	Simulation Modeling to Improve HIV/HCV Screening, Treatment and Care	5R01DA031059-03	13
2013	Simulation Modeling to Improve HIV/HCV Screening, Treatment and Care	5R01DA031059-02	13
2012	Simulation Modeling to Improve HIV/HCV Screening, Treatment and Care	1R01DA031059-01A1	13
2011	Improving HIV and HCV outcomes in U.S. AIDS Drug Assistance Programs	5K01AI073193-05	6
2010	Improving HIV and HCV outcomes in U.S. AIDS Drug Assistance Programs	5K01AI073193-04	6
2009	Improving HIV and HCV outcomes in U.S. AIDS Drug Assistance Programs	5K01AI073193-03	6

Showing 10 of 12 results. Show All Results

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

Freiman JM, Jacobson KR, Muyindike WR, Horsburgh CR, Ellner JJ, Hahn JA, Linas BP. Isoniazid Preventive Therapy for People With HIV Who Are Heavy Alcohol Drinkers in High TB-/HIV-Burden Countries: A Risk-Benefit Analysis. J Acquir Immune Defic Syndr. 2018 Apr 01; 77(4):405-412.View Related Profiles.

Linas, Benjamin
Ellner, Jerrold
Freiman, Julie
Jacobson, Karen

PMID: 29239900.

Saag LA, LaValley MP, Hochberg NS, Cegielski JP, Pleskunas JA, Linas BP, Horsburgh CR. Low body mass index and latent tuberculous infection: a systematic review and meta-analysis. Int J Tuberc Lung Dis. 2018 Apr 01; 22(4):358-365.View Related Profiles.

Linas, Benjamin
LaValley, Michael
Hochberg, Natasha

PMID: 29562981; DOI: 10.5588/ijtld.17.0558;.

Murphy SM, Leff JA, Linas BP, Morgan JR, McCollister K, Schackman BR. Implementation of a nationwide health economic consultation service to assist substance use researchers: Lessons learned. Subst Abus. 2018 Mar 20; 1-19. PMID: 29558284.

Chow FC, Wilson MR, Wu K, Ellis RJ, Bosch RJ, Linas BP. Stroke incidence is highest in women and non-Hispanic Blacks living with HIV in the ALLRT cohort. AIDS. 2018 Mar 15. PMID: 29547443.

Schackman BR, Gutkind S, Morgan JR, Leff JA, Behrends CN, Delucchi KL, McKnight C, Perlman DC, Masson CL, Linas BP. Cost-effectiveness of hepatitis C screening and treatment linkage intervention in US methadone maintenance treatment programs. Drug Alcohol Depend. 2018 Apr 01; 185:411-420. PMID: 29477574.

Akiyama MJ, Agyemang L, Arnsten JH, Heo M, Norton BL, Schackman BR, Linas BP, Litwin AH. Rationale, design, and methodology of a trial evaluating three models of care for HCV treatment among injection drug users on opioid agonist therapy. BMC Infect Dis. 2018 02 09; 18(1):74. PMID: 29426304.

Leech AA, Bortoletto P, Christiansen C, Drainoni ML, Linas BP, Roeca C, Curtis M, Sullivan M. Assessing access to assisted reproductive services for serodiscordant couples with human immunodeficiency virus infection. Fertil Steril. 2018 Mar; 109(3):473-477.View Related Profiles.

Linas, Benjamin
Drainoni, Mari-Lynn

PMID: 29428310.

Barocas JA, Tasillo A, Eftekhari Yazdi G, Wang J, Vellozzi C, Hariri S, Isenhour C, Randall L, Ward JW, Mermin J, Salomon JA, Linas BP. Population level outcomes and cost-effectiveness of expanding the recommendation for age-based hepatitis C testing in the United States. Clin Infect Dis. 2018 Feb 06. PMID: 29420742.

Assoumou SA, Tasillo A, Leff JA, Schackman BR, Drainoni ML, Horsburgh CR, Barry MA, Regis C, Kim AY, Marshall A, Saxena S, Smith PC, Linas BP. Cost-Effectiveness of One-Time Hepatitis C Screening Strategies Among Adolescents and Young Adults in Primary Care Settings. Clin Infect Dis. 2018 Jan 18; 66(3):376-384.View Related Profiles.

Linas, Benjamin
Horsburgh, C.
Barry, M.
Drainoni, Mari-Lynn
Smith, Peter
Assoumou, Sabrina

PMID: 29020317.

Morgan JR, Kim AY, Naggie S, Linas BP. The Effect of Shorter Treatment Regimens for Hepatitis C on Population Health and Under Fixed Budgets. Open Forum Infect Dis. 2018 Jan; 5(1):ofx267. PMID: 29354660.

Showing 10 of 50 results. Show More

Barocas JA, Wang J, White LF, Tasillo A, Salomon JA, Freedberg KA, Linas BP. Hepatitis C Testing Increased Among Baby Boomers Following The 2012 Change To CDC Testing Recommendations. Health Aff (Millwood). 2017 Dec; 36(12):2142-2150.View Related Profiles.

Linas, Benjamin
White, Laura

PMID: 29200354.

Tasillo A, Salomon JA, Trikalinos TA, Horsburgh CR, Marks SM, Linas BP. Cost-effectiveness of Testing and Treatment for Latent Tuberculosis Infection in Residents Born Outside the United States With and Without Medical Comorbidities in a Simulation Model. JAMA Intern Med. 2017 Dec 01; 177(12):1755-1764.View Related Profiles.

Linas, Benjamin
Horsburgh, C.

PMID: 29049814.

Cohen GH, Tamrakar S, Lowe S, Sampson L, Ettman C, Linas B, Ruggiero K, Galea S. Comparison of Simulated Treatment and Cost-effectiveness of a Stepped Care Case-Finding Intervention vs Usual Care for Posttraumatic Stress Disorder After a Natural Disaster. JAMA Psychiatry. 2017 Dec 01; 74(12):1251-1258.View Related Profiles.

Linas, Benjamin
Galea, Sandro

PMID: 28979968.

Morgan JR, Servidone M, Easterbrook P, Linas BP. Economic evaluation of HCV testing approaches in low and middle income countries. BMC Infect Dis. 2017 Nov 01; 17(Suppl 1):697. PMID: 29143681.

Losina E, Hyle EP, Borre ED, Linas BP, Sax PE, Weinstein MC, Rusu C, Ciaranello AL, Walensky RP, Freedberg KA. Projecting 10-year, 20-year, and Lifetime Risks of Cardiovascular Disease in Persons Living With Human Immunodeficiency Virus in the United States. Clin Infect Dis. 2017 10 15; 65(8):1266-1271. PMID: 28605504.

Morgan JR, Schackman BR, Leff JA, Linas BP, Walley AY. Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population. J Subst Abuse Treat. 2018 Feb; 85:90-96.View Related Profiles.

Walley, Alexander
Linas, Benjamin

PMID: 28733097.

Barocas JA, Beiser M, León C, Gaeta JM, O''Connell JJ, Linas BP. Experience and Outcomes of Hepatitis C Treatment in a Cohort of Homeless and Marginally Housed Adults. JAMA Intern Med. 2017 Jun 01; 177(6):880-882.View Related Profiles.

Linas, Benjamin
Gaeta, Jessie

PMID: 28395004; DOI: 10.1001/jamainternmed.2017.0358;.

Assoumou SA, Huang W, Young K, Horsburgh CR, Linas BP. Real-world Outcomes of Hepatitis C Treatment during the Interferon-free Era at an Urban Safety-net Hospital. J Health Care Poor Underserved. 2017; 28(4):1333-1344.View Related Profiles.

Linas, Benjamin
Horsburgh, C.
Assoumou, Sabrina

PMID: 29176099.

Linas BP, Morgan JR, Pho MT, Leff JA, Schackman BR, Horsburgh CR, Assoumou SA, Salomon JA, Weinstein MC, Freedberg KA, Kim AY. Cost Effectiveness and Cost Containment in the Era of Interferon-Free Therapies to Treat Hepatitis C Virus Genotype 1. Open Forum Infect Dis. 2017; 4(1):ofw266.View Related Profiles.

Linas, Benjamin
Horsburgh, C.
Assoumou, Sabrina

PMID: 28480259.

Barocas JA, Linas BP. Editorial Commentary: Decision Science at Work: The Case of Hepatitis C Virus Postexposure Prophylaxis. Clin Infect Dis. 2017 Jan 01; 64(1):100-101. PMID: 27815292.

Linas BP. Understanding Cost and Value in Hepatitis C Therapy. Top Antivir Med. 2016 Jul/Aug; 24(2):93-97. PMID: 27841979.

Freiman JM, Tran TM, Schumacher SG, White LF, Ongarello S, Cohn J, Easterbrook PJ, Linas BP, Denkinger CM. Hepatitis C Core Antigen Testing for Diagnosis of Hepatitis C Virus Infection: A Systematic Review and Meta-analysis. Ann Intern Med. 2016 Sep 06; 165(5):345-55.View Related Profiles.

Linas, Benjamin
Freiman, Julie
White, Laura

PMID: 27322622; DOI: 10.7326/M16-0065;.

Barocas JA, Linas BP, Kim AY, Fangman J, Westergaard RP. Acceptability of Rapid Point-of-Care Hepatitis C Tests Among People Who Inject Drugs and Utilize Syringe-Exchange Programs. Open Forum Infect Dis. 2016 Mar; 3(2):ofw075. PMID: 27191007; DOI: 10.1093/ofid/ofw075;.

Carey KJ, Huang W, Linas BP, Tsui JI. Hepatitis C Virus Testing and Treatment Among Persons Receiving Buprenorphine in an Office-Based Program for Opioid Use Disorders. J Subst Abuse Treat. 2016 Jul; 66:54-9. PMID: 26988423; DOI: 10.1016/j.jsat.2016.01.009;.

Young KL, Huang W, Horsburgh CR, Linas BP, Assoumou SA. Eighteen- to 30-year-olds more likely to link to hepatitis C virus care: an opportunity to decrease transmission. J Viral Hepat. 2016 Apr; 23(4):274-81.View Related Profiles.

Linas, Benjamin
Horsburgh, C.
Assoumou, Sabrina

PMID: 26572798; DOI: 10.1111/jvh.12489;.

Pho MT, Jensen DM, Meltzer DO, Kim AY, Linas BP. Clinical impact of treatment timing for chronic hepatitis C infection: a decision model. J Viral Hepat. 2015 Aug; 22(8):630-8. PMID: 26135026; PMCID: PMC4515086; DOI: 10.1111/jvh.12412;.

Linas BP, Barter DM, Morgan JR, Pho MT, Leff JA, Schackman BR, Horsburgh CR, Assoumou SA, Salomon JA, Weinstein MC, Freedberg KA, Kim AY. The cost-effectiveness of sofosbuvir-based regimens for treatment of hepatitis C virus genotype 2 or 3 infection. Ann Intern Med. 2015 May 5; 162(9):619-29.View Related Profiles.

Linas, Benjamin
Horsburgh, C.
Assoumou, Sabrina

PMID: 25820703; PMCID: PMC4420667; DOI: 10.7326/M14-1313;.

Linas BP. Potential Impact and Cost-effectiveness of Self-Testing for HIV in Low-Income Countries. J Infect Dis. 2015 Aug 15; 212(4):513-5. PMID: 25767215; DOI: 10.1093/infdis/jiv041;.

Schackman BR, Leff JA, Barter DM, DiLorenzo MA, Feaster DJ, Metsch LR, Freedberg KA, Linas BP. Cost-effectiveness of rapid hepatitis C virus (HCV) testing and simultaneous rapid HCV and HIV testing in substance abuse treatment programs. Addiction. 2015 Jan; 110(1):129-43. PMID: 25291977; PMCID: PMC4270906; DOI: 10.1111/add.12754;.

Freiman JM, Huang W, White LF, Geng EH, Hurt CB, Taylor LE, Overton ET, Cachay ER, Kitahata MM, Moore RD, Rodriguez B, Mayer KH, Linas BP. Current practices of screening for incident hepatitis C virus (HCV) infection among HIV-infected, HCV-uninfected individuals in primary care. Clin Infect Dis. 2014 Dec 15; 59(12):1686-93.View Related Profiles.

Linas, Benjamin
Freiman, Julie
White, Laura

PMID: 25186591; PMCID: PMC4311177; DOI: 10.1093/cid/ciu698;.

Pho MT, Linas BP. Valuing cure: bridging cost-effectiveness and coverage decisions for hepatitis C therapy. Hepatology. 2014 Jul; 60(1):12-4. PMID: 24825115; PMCID: PMC4096113; DOI: 10.1002/hep.27220;.

Linas BP, Barter DM, Leff JA, Assoumou SA, Salomon JA, Weinstein MC, Kim AY, Schackman BR. The hepatitis C cascade of care: identifying priorities to improve clinical outcomes. PLoS One. 2014; 9(5):e97317.View Related Profiles.

Linas, Benjamin
Assoumou, Sabrina

PMID: 24842841; PMCID: PMC4026319; DOI: 10.1371/journal.pone.0097317;.

Assoumou SA, Huang W, Horsburgh CR, Drainoni ML, Linas BP. Relationship between hepatitis C clinical testing site and linkage to care. Open Forum Infect Dis. 2014 Mar; 1(1):ofu009.View Related Profiles.

Linas, Benjamin
Horsburgh, C.
Drainoni, Mari-Lynn
Assoumou, Sabrina

PMID: 25734083; DOI: 10.1093/ofid/ofu009;.

Assoumou SA, Huang W, Horsburgh CR, Mus, Linas BP. Quality of hepatitis C care at an urban tertiary care medical center. J Health Care Poor Underserved. 2014 May; 25(2):705-16.View Related Profiles.

Linas, Benjamin
Horsburgh, C.
Assoumou, Sabrina

PMID: 24858880; PMCID: PMC4541792; DOI: 10.1353/hpu.2014.0093;.

Linas BP, Barter DM, Leff JA, DiLorenzo M, Schackman BR, Horsburgh CR, Assoumou SA, Salomon JA, Weinstein MC, Kim AY, Freedberg KA. The cost-effectiveness of improved hepatitis C virus therapies in HIV/hepatitis C virus coinfected patients. AIDS. 2014 Jan 28; 28(3):365-76.View Related Profiles.

Linas, Benjamin
Horsburgh, C.
Assoumou, Sabrina

PMID: 24670522; PMCID: PMC4045405; DOI: 10.1097/QAD.0000000000000093;.

Linas BP, Hu H, Barter DM, Horberg M. Hepatitis C screening trends in a large integrated health system. Am J Med. 2014 May; 127(5):398-405. PMID: 24486288; PMCID: PMC3999187; DOI: 10.1016/j.amjmed.2014.01.012;.

Taylor LE, Foont JA, DeLong AK, Wurcel A, Linas BP, Chapman S, Maynard MA, Cu-Uvin S, Mayer KH. The spectrum of undiagnosed hepatitis C virus infection in a US HIV clinic. AIDS Patient Care STDS. 2014 Jan; 28(1):4-9. PMID: 24428794; PMCID: PMC3894677; DOI: 10.1089/apc.2013.0130;.

Assoumou SA, Mayer KH, Panther L, Linas BP, Kim J. Cost-effectiveness of surveillance strategies after treatment for high-grade anal dysplasia in high-risk patients. Sex Transm Dis. 2013 Apr; 40(4):298-303.View Related Profiles.

Linas, Benjamin
Assoumou, Sabrina

PMID: 23486494; PMCID: PMC3780795; DOI: 10.1097/OLQ.0b013e31827f4fe9;.

Spaulding AS, Kim AY, Harzke AJ, Sullivan JC, Linas BP, Brewer A, Dickert J, McGovern BH, Strick LB, Trestman R, Ferguson WJ. Impact of new therapeutics for hepatitis C virus infection in incarcerated populations. Top Antivir Med. 2013 Feb-Mar; 21(1):27-35. PMID: 23596276.

Linas BP, Wong AY, Schackman BR, Kim AY, Freedberg KA. Cost-effective screening for acute hepatitis C virus infection in HIV-infected men who have sex with men. Clin Infect Dis. 2012 Jul; 55(2):279-90. PMID: 22491339; PMCID: PMC3403839; DOI: 10.1093/cid/cis382;.

Linas BP, Wong AY, Freedberg KA, Horsburgh CR. Priorities for screening and treatment of latent tuberculosis infection in the United States. Am J Respir Crit Care Med. 2011 Sep 1; 184(5):590-601.View Related Profiles.

Linas, Benjamin
Horsburgh, C.

PMID: 21562129; PMCID: PMC3175546; DOI: 10.1164/rccm.201101-0181OC;.

Linas BP, Wang B, Smurzynski M, Losina E, Bosch RJ, Schackman BR, Rong J, Sax PE, Walensky RP, Schouten J, Freedberg KA. The impact of HIV/HCV co-infection on health care utilization and disability: results of the ACTG Longitudinal Linked Randomized Trials (ALLRT) Cohort. J Viral Hepat. 2011 Jul; 18(7):506-12. PMID: 20546501; PMCID: PMC3347883; DOI: 10.1111/j.1365-2893.2010.01325.x;.

Linas BP, Losina E, Rockwell A, Walensky RP, Cranston K, Freedberg KA. Improving outcomes in state AIDS drug assistance programs. J Acquir Immune Defic Syndr. 2009 Aug 15; 51(5):513-21. PMID: 19561518; PMCID: PMC2774843; DOI: 10.1097/QAI.0b013e3181b16d00;.

Ehrenkranz PD, Pagán JA, Begier EM, Linas BP, Madison K, Armstrong K. Written informed-consent statutes and HIV testing. Am J Prev Med. 2009 Jul; 37(1):57-63. PMID: 19423271; PMCID: PMC2800306; DOI: 10.1016/j.amepre.2009.03.011;.

Linas BP, Zheng H, Losina E, Rockwell A, Walensky RP, Cranston K, Freedberg KA. Optimizing resource allocation in United States AIDS drug assistance programs. Clin Infect Dis. 2006 Nov 15; 43(10):1357-64. PMID: 17051505.

Linas BP, Zheng H, Losina E, Walensky RP, Freedberg KA. Assessing the impact of federal HIV prevention spending on HIV testing and awareness. Am J Public Health. 2006 Jun; 96(6):1038-43. PMID: 16670217; PMCID: PMC1470622.

Linas BP, Coffin PO, Backes G, Vlahov D. New York State pharmacists'' attitudes toward needle and syringe sales to injection drug users before implementation of syringe deregulation. J Urban Health. 2000 Dec; 77(4):768-80. PMID: 11194316; PMCID: PMC3456767.

Coffin PO, Linas BP, Factor SH, Vlahov D. New York City pharmacists'' attitudes toward sale of needles/syringes to injection drug users before implementation of law expanding syringe access. J Urban Health. 2000 Dec; 77(4):781-93. PMID: 11194317; PMCID: PMC3456774.

Sulmasy DP, Linas BP, Gold KF, Schulman KA. Physician resource use and willingness to participate in assisted suicide. Arch Intern Med. 1998 May 11; 158(9):974-8. PMID: 9588430.

Schulman KA, Linas BP. Pharmacoeconomics: state of the art in 1997. Annu Rev Public Health. 1997; 18:529-48. PMID: 9143730.

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 50 publications over 14 distinct years, with a maximum of 9 publications in 2017 and 2018

Bar chart showing 50 publications over 14 distinct years, with a maximum of 9 publications in 2017 and 2018

Year	Publications
1997	1
1998	1
2000	2
2006	2
2009	2
2010	1
2011	1
2012	1
2013	2
2014	8
2015	5
2016	6
2017	9
2018	9

In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Viral Hepatitis Hepatitis C Virus HIV infection Comparative effectiveness Cost-Effectiveness Simulation modeling Data analytics Transmission modeling Health Economics Health Policy

Contact for Mentoring:

771 Albany St
Boston MA 02118
Google Map

617.414.5238

Download vCard

Linas's Networks

Click the "See All" links for more information and interactive visualizations

Concepts

See all (189) concept(s)

Co-Authors

See all (13) people

Similar People

See all (60) people

Same Department

Search Department